Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike R Sather

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Therapeutics|April 7, 2005
Assessment of the impact of a patient clinical trials handbook among pharmacy studentsA Christie Graham, Dennis W Raisch, Carol L Fye, et al.
The Annals of Pharmacotherapy|February 19, 2002
Opioid dependence treatment, including buprenorphine/naloxoneDennis W Raisch, Carol L Fye, Kathy D Boardman, et al.
American Journal of Pharmaceutical Education|November 14, 2007
Pharmacy students' knowledge, attitudes, and evaluation of direct-to-consumer advertisingRupali K Naik, Matthew E Borrego, Gireesh V Gupchup, et al.
Controlled Clinical Trials|September 23, 2003
Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies ProgramMike R Sather, Dennis W Raisch, Clair M Haakenson, et al.
Military Medicine|February 6, 2007
A comparison of veteran and nonveteran motivations and reasons for participating in clinical trialsHeather M Campbell, Dennis W Raisch, Mike R Sather, et al.
The Annals of Pharmacotherapy|October 19, 2006
GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugsCrystal L Harris, Dennis W Raisch, Upendra Abhyankar, et al.
Diabetes Research and Clinical Practice|November 5, 2013
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetesHeather M Campbell, Nasreen Khan, Dennis W Raisch, et al.
Contemporary Clinical Trials Communications|December 25, 2018
Impact of Department of Veterans Affairs Cooperative Studies Program clinical trials on practice guidelines for high blood pressure managementAdam M Henrie, Mike R Sather, Ludmila N Bakhireva, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 12, 2011
Health-related quality of life changes associated with buprenorphine treatment for opioid dependenceDennis W Raisch, Heather M Campbell, David A Garnand, et al.
Controlled Clinical Trials|December 4, 2003
The role of the pharmacy coordinating center in the DIG trialCarol L Fye, William H Gagne, Dennis W Raisch, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Therapeutics|April 7, 2005
Assessment of the impact of a patient clinical trials handbook among pharmacy studentsA Christie Graham, Dennis W Raisch, Carol L Fye, et al.
The Annals of Pharmacotherapy|February 19, 2002
Opioid dependence treatment, including buprenorphine/naloxoneDennis W Raisch, Carol L Fye, Kathy D Boardman, et al.
American Journal of Pharmaceutical Education|November 14, 2007
Pharmacy students' knowledge, attitudes, and evaluation of direct-to-consumer advertisingRupali K Naik, Matthew E Borrego, Gireesh V Gupchup, et al.
Controlled Clinical Trials|September 23, 2003
Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies ProgramMike R Sather, Dennis W Raisch, Clair M Haakenson, et al.
Military Medicine|February 6, 2007
A comparison of veteran and nonveteran motivations and reasons for participating in clinical trialsHeather M Campbell, Dennis W Raisch, Mike R Sather, et al.
The Annals of Pharmacotherapy|October 19, 2006
GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugsCrystal L Harris, Dennis W Raisch, Upendra Abhyankar, et al.
Diabetes Research and Clinical Practice|November 5, 2013
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetesHeather M Campbell, Nasreen Khan, Dennis W Raisch, et al.
Contemporary Clinical Trials Communications|December 25, 2018
Impact of Department of Veterans Affairs Cooperative Studies Program clinical trials on practice guidelines for high blood pressure managementAdam M Henrie, Mike R Sather, Ludmila N Bakhireva, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 12, 2011
Health-related quality of life changes associated with buprenorphine treatment for opioid dependenceDennis W Raisch, Heather M Campbell, David A Garnand, et al.
Controlled Clinical Trials|December 4, 2003
The role of the pharmacy coordinating center in the DIG trialCarol L Fye, William H Gagne, Dennis W Raisch, et al.
Pageof 2